Skip to content

Clinical Study on Chai Shu Yi Shen Decoction for Posterior Circulation Ischemic Vertigo with Shaoyang Pivot Disorder and Kidney Essence Deficiency Syndrome

Clinical Study on Chai Shu Yi Shen Decoction for Posterior Circulation Ischemic Vertigo with Shaoyang Pivot Disorder and Kidney Essence Deficiency Syndrome

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2026000377
Enrollment
Unknown
Registered
2026-02-13
Start date
2026-03-01
Completion date
Unknown
Last updated
2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Posterior Circulation Ischemic Vertigo, Shaoyang Pivot Disorder Complicated with Kidney Essence Deficiency Syndrome

Interventions

Treatment Group:Chai Shu Yi Shen Decoction
Control Group:Aspirin Enteric-coated Tablets plus Betahistine Hydrochloride Tablets

Sponsors

Panjin City Hospital of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Meets the diagnostic criteria for posterior circulation ischemia (refer to the "Chinese Expert Consensus on Posterior Circulation Ischemia"). 2. Confirmed by TCD that VA/BA blood flow velocity is reduced. 3. TCM syndrome differentiation: "Unsmooth Shaoyang (Shuji) with deficiency of kidney essence" (main symptoms: vertigo, bitter mouth and dry throat, discomfort in the chest and (xie), soreness and weakness in the waist and knees, tinnitus; secondary symptoms: irritability, alternating chills and fever, tinnitus with forgetfulness, thin and wiry pulse). 4. Age between 40-75 years old, signed informed consent.

Exclusion criteria

Exclusion criteria: 1. Posterior circulation infarction, intracerebral hemorrhage, and other severe cerebrovascular diseases. 2. Impaired liver and kidney function, severe cardiovascular diseases. 3. Allergy to the investigational drug. 4. Use of similar Chinese herbal medicine or drugs affecting blood flow within the past month.

Design outcomes

Primary

MeasureTime frame
Color Doppler Ultrasound of Vertebrobasilar Artery;

Secondary

MeasureTime frame
TCM Syndrome Score;Dizziness Handicap Inventory;

Countries

China

Contacts

Public ContactTan Zhong Yu

Panjin City Hospital of Traditional Chinese Medicine

18742303686@163.com18742303686

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Mar 14, 2026